Jardiance Injury Lawyers
Have you or a loved one suffered an injury due to taking the diabetes medication Jardiance? If so you may be entitled to benefits as well as monetary compensation. Speaking with, and ultimately retaining, a skilled Jardiance injury attorney is a wise move.
Please contact our Jardiance injury lawyers here for a free consultation. They handle Jardiance cases, which are mass tort claims, on a contingency fee basis which means they charge no legal fees of any kind unless they win for you.
What Is Jardiance?
In 2014, Boehringer Ingelheim introduced the diabetes drug Jardiance. This new drug is part of a class of medications known as SGLT2 inhibitors. Jardiance is the brand name of empagliflozin, a Type 2 diabetes treatment. It is an oral diabetic medication that helps control blood sugar levels by helping the kidneys get rid of glucose in the bloodstream.
Common side effects experienced by users of Jardiance include the following:
- Urinary tract infection
- Decreased blood pressure
- Yeast infection
- Decreased kidney function
In May 2015, the Food and Drug Administration (FDA) issued a safety warning regarding the risk of people developing diabetic ketoacidosis (DKA). The FDA received 20 reports between March 2013 and June 2014 of patients developing DKA after taking Jardiance. DKA occurs when there is an accumulation of high levels of acid in blood. If not properly treated, DKA can lead to brain swelling, coma and even death. DKA results in patients developing the following complications:
- Shortness of breath
- Nausea or vomiting
- Abdominal pain
- Severe fatigue
- Increased urination and thirst
In December 2015, the FDA announced Boehringer Ingelheim would have to issue a warning to consumers regarding the dangers of developing DKA after taking Jardiance.
The European Medicines Agency (EMA) also published a review of SGLT2 inhibitor risks. The EMA urged healthcare providers to examine patients for DKA symptoms while taking any SGLT2 inhibitors. If you are currently experiencing any of the symptoms mentioned above while taking Jardiance, contact your doctor for medical treatment. Do not stop taking Jardiance without first obtaining medical advice from your treating physician.
Mass Tort Lawyers Taking Jardiance Lawsuit Cases
Patients across the country who have developed medical complications after taking Jardiance are pursuing legal remedies. Patients have alleged Boehringer Ingelheim withheld information about the dangerous side effects of Jardiance from patients and medical professionals. If the company would have provided the public with stronger warnings regarding the dangers of its drug, several consumers would have been able to avoid health complications after taking Jardiance.
In addition to developing DKA as a result of taking Jardiance, some patients have also developed kidney failure. SGLT2 inhibitors like Jardiance impacts the normal functioning of the kidneys. Several patients have reported the following kidney conditions after taking Jardiance:
- Kidney failure
- Kidney stones
- Urinary tract infection
- Kidney infection
In order to prevail in a civil action for damages against Boehringer Ingelheim, a plaintiff will have to prove that Jardiance was the direct and actual cause of him/her developing DKA and resulting complications such as coma, kidney failure, or death. Depending on the extent of the injury suffered, a plaintiff may be able to recover the following types of compensation:
- Lost wages
- Medical expenses
- Pain and suffering
- Emotional distress
If you have experienced DKA symptoms after taking Jardiance, contact our law office for a consultation. We can provide you with legal advice and guidance on filing a claim. Do not delay in filing a claim. Doing so can bar you from obtaining compensation for damages. We are currently providing legal representation to patients who suffered medical complications after taking Jardiance
No matter what state you were injured in our team of Jardiance mass tort lawyers and wrongful death attorneys can help as they serve all 50 states and Washington D.C. including: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington D.C., West Virginia and Wisconsin.